Executive Summary
Childhood Acute Lymphoblastic Leukemia (ALL) represents more than a quarter of all pediatric cancers and is a blood cancer. It is the cancer of the lymphocytes, a type of white blood cell involved in the body’s immune system. ...
Executive Summary
Childhood acute Lymphoblastic Leukemia is the most common type of childhood cancer, affecting almost 74% of people under the age group of 20. Most cases occur between ages 2 and 5 and are less common in girls than boys. The 5-y...
Executive Summary
Risk factors influence the chances of developing cancer (childhood acute lymphoblastic leukemia) among individuals. But individuals with no risk factors also develop this cancer. Although doctors do not know what causes most chi...
Executive Summary
Studies are still evaluating the factors accountable for causing childhood acute lymphoblastic leukemia, thereby devising ways to prevent these diseases. Since most people with acute lymphocytic leukemia do not have many risk fa...
Executive Summary
Childhood acute lymphoblastic leukemia is diagnosed based on its symptoms. The signs and symptoms of childhood ALL experienced by the individuals help describe the medical condition. The most common symptoms of childhood ALL inc...
Executive Summary
Several diagnostic tests are conducted to determine childhood acute lymphoblastic leukemia. The main procedures used to diagnose childhood acute lymphoblastic leukemia are the medical history of the patient, complete blood cell ...
Executive Summary
Unlike other types of cancer, there is no staging system for childhood acute lymphoblastic leukemia. Doctors plan the treatment based on factors involving age (infants younger than 12 months and children age ten and older), whit...
Executive Summary
Treatment for Childhood Acute Lymphoblastic Leukemia recommendations depends upon the state of Acute Lymphoblastic Leukemia of the individual. Appropriate treatment continues to control leukemia from recurring. Recurrent ALL is ...
Executive Summary
Clinical trials are considered a better method for treating childhood acute lymphoblastic leukemia. The evaluation of new drugs, different combinations of treatments, new approaches to surgery, and new therapies are also a part ...
Executive Summary
Several latest research studies are underway to seek more information on childhood acute lymphoblastic leukemia, related prevention methods, diagnostic process at the initial phase, and best treatment strategies. New methods for...
Executive Summary
Treatments of childhood acute lymphoblastic leukemia can cause various side effects and changes to the patient’s body. The results of treatment can also show variations among the patients. Sometimes the same treatment strategy...
Executive Summary
Follow-up care for childhood acute lymphoblastic leukemia refers to the after-treatment protocols conducted by the healthcare team to look after recurrence, manage the side effects, and monitor the overall health of the patient....
Executive Summary
Survivorship begins after the disease (childhood acute lymphoblastic leukemia) is diagnosed. People who have been taking treatments and whose disease condition has been cured post-treatment are also considered survivors. Survivo...
When making up your mind about treatment for Childhood Acute Lymphoblastic Leukemia, you must know every detail about the treatment you opt for. It would be best to ask questions about anything about cancer that you don't understand.
Don't forget...
Resources for Childhood Acute Lymphoblastic Leukemia
Here are a few links -
https://www.cancer.net/cancer-types/leukemia-acute-lymphoblastic-all-childhoodhttps://emedicine.medscape.com/article/990113-overviewhttps://www.haematologica.org/artic...
